Evidence map›Paper›PMID 35464114›Full record

ArticleEducation and information technologies2022

A web-based survey of educational opportunities of medical professionals based on changes in conference design during the COVID-19 pandemic.

Kenta Yagi, Yasutaka Sato, Satoshi Sakaguchi, Mitsuhiro Goda, Hirofumi Hamano, Fuka Aizawa, Mayuko Shimizu, Arisa Inoue-Hamano, Toshihide Nishimori, Masato Tagi and 13 more

Abstract read
In one paragraph

Article in Education and information technologies, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Kenta YagiClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, 770-8503 Japan.ORCID 0000-0003-0869-5786
Yasutaka SatoClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, 770-8503 Japan.
Satoshi SakaguchiClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, 770-8503 Japan.
Mitsuhiro GodaDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Hirofumi HamanoClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, 770-8503 Japan.
Fuka AizawaDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Mayuko ShimizuDepartment of Pathology and Laboratory Medicine, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Arisa Inoue-HamanoDepartment of Therapeutic Nutrition, Institute of Biomedical Sciences, Tokushima University Graduate School, Tokushima, Japan.
Toshihide NishimoriDepartment of Nursing, Tokushima University Hospital, Tokushima, Japan.
Masato TagiDepartment of Medical Informatics, Tokushima University Graduate School of Biomedical Sciences, Tokushima, Japan.
Marina KannoDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Rie Matsuoka-AndoDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Toshihiko YoshiokaDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Yoshiko MatstubaraDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.
Yuki Izawa-IshizawaDepartment of Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Rieko ShimizuDivision of Oral and Maxillofacial Surgery, Kagawa Prefectural Central Hospital, Kagawa, Japan.
Akinori MaruoDepartment of Pharmacy, Okayama University Hospital, Okayama, Japan.
Yurika KunikiDepartment of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Yoshika SakamotoDepartment of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Sayuri ItobayashiDepartment of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Yoshito ZamamiDepartment of Clinical Pharmacology and Therapeutics, University of Tokushima Graduate School of Biomedical Sciences, Tokushima, Japan.
Hiroaki YanagawaClinical Research Center for Developmental Therapeutics, Tokushima University Hospital, 2-50-1 Kuramoto-cho, Tokushima, 770-8503 Japan.
Keisuke IshizawaDepartment of Pharmacy, Tokushima University Hospital, Tokushima, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Owing to the coronavirus disease 2019 (COVID-19) pandemic, understanding how to hold future online academic conferences effectively is imperative. We assessed the impact of COVID-19 on academic conferences, including facilities and settings for attendance, participation status, cost burden, and preferences for future styles of holding conferences, through a web-based questionnaire survey of 2,739 Japanese medical professionals, from December 2020 to February 2021. Of the participants, 28% preferred web conferences, 60% preferred a mix of web and on-site conferences, and 12% preferred on-site conferences. Additionally, 27% of the presenters stopped presenting new findings at web conferences. The proportion of participants who audio-recorded or filmed the sessions, despite prohibition, was six times higher at web than face-to-face conferences. Since the COVID-19 outbreak, the percentage of participants attending general presentations decreased from 91 to 51%. While web conferencing offers advantages, these are offset by a decrease in presentations pertaining to novel findings and data. Supplementary Information: The online version contains supplementary material available at 10.1007/s10639-022-11032-5.

Indexed as

Adult learningDistance educationLifelong learningOnline learning

Identifiers

PMID35464114
PMCPMC9013632

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.